Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

10 Best ETFs for 2020: The Race Tightens With ‘New Normal’ Looming Ahead

The landscape for best ETFs in 2020 has changed after the novel coronavirus pandemic with technology and cloud companies leading the bunch.

Buy Canopy Growth Stock Before Positive Momentum Returns

A major needle-mover around the corner could lead CGC stock to trend higher again. Get ahead of the crowd by buying today's pullback.

The Top 15 Stocks to Buy in 2020

The coronavirus pandemic has created once-in-a-lifetime buying opportunities in these strong stocks to buy for 2020.

4 Marijuana Stocks to Buy for the Big 2020 Rally

The marijuana stock rebound in 2020 has run into a brick wall, but the fundamentals supporting the industry continue to improve.

7 Marijuana Stocks for Loyal Cannabis Bulls

Marijuana stocks remain near the lows, and many remain challenged. But these seven names have the potential to rally through sector fears.

Hexo Stock Still Has a Major Cash Problem

Don't bother buying Hexo stock here. Instead, look for stronger cannabis stocks that have better balance sheets and bigger potential.

Buy Canopy Growth Stock as Cannabis Again Enters the Spotlight

Canopy Growth stock has been trading better lately, giving investors a glimpse of what CGC stock can do if it regains momentum.

Canopy Growth Has a Catalyst That Few Are Talking About

The devastation from the coronavirus spared very few sectors and marijuana wasn’t one of them. However, this has created a long-term catalyst for CGC stock that few are talking about.

Only a Miracle Can Save Tilray Stock Now

TLRY stock is down over 97% in under two years, and there's no stopping the free fall as the company struggles on multiple fronts.

Buy the Post-Earnings Dip in Canopy Growth Stock Now

Canopy Growth's fourth-quarter earnings report was not good. But the big-picture trends remain favorable, and CGC stock will bounce back.

Canopy Growth Stock Is Still Among the Most Compelling Marijuana Plays

CGC stock is well-positioned to become a leader in the cannabis industry with its steady partnership with a beverage industry giant.

Tilray Stock Is a Loser in the Cannabis World

Compared to its innovative peers like Cronos and Canopy Growth, Tilray is destined to fail. That's why investors should avoid TLRY stock now.

Constellation Brands Must Exercise Warrants to Keep Canopy Growth Alive

Canadian Canopy Growth is burning through cash way too quickly. That's why CGC stock is relying on Constellation Brands for survival.

3 Numbers to Study Before Jumping on the Tilray Bandwagon

Before you decide to buy or sell Tilray stock and move on to another cannabis play, at least take the time to consider three numbers from its quarterly report. I won’t say which way I’m leaning toward Tilray until the end -- the last time I wrote about TLRY in November, I cautioned investors to wait for a catalyst before buying -- but I can say that Tilray’s business isn’t nearly as bad as the headlines suggest. 

Is It Time to Join the Party and Double Down on Canopy Growth Stock?

If anyone's wondering whether Constellation Brands is confident in its CGC stock holdings, here's your answer.

A Reverse Stock Split Was Too Little, Too Late to Save Aurora Cannabis Stock

With weak fundamentals, and the potential for shares to drop further, sell Aurora stock and consider better pot plays elsewhere.

Is Aurora Stock Worth Owning After Its Reverse Split?

The threat of dilution is real so prospective Aurora stockholders might consider other cannabis-sector investments instead.

Canopy Growth Stock has Upside Potential Emerging From This Covid-19 Hole

At one point pot stocks were all the rage. CGC stock is trying to make a comeback in spite of the drubbing it took during the Covid-19 crash.

Slimmed-Down Canopy Growth Stock Is a Cannabis Winner

Investors are punishing CGC stock for cost-cutting measures, but Canopy Growth now is more likely to survive Covid-19 than its bigger peers.

Why Investors Should Bet on Canopy Growth Now as it Readies for Later

CGC stock got a lift from production closures worldwide, so as its cost basis shrinks, Canopy Growth will eventually earn profits.